|Year : 2022 | Volume
| Issue : 1 | Page : 17-21
Evaluation of 0.25% bupivacaine vs. 0.375% ropivacaine for postoperative analgesia using ultrasound guided transversus abdominis plane block for caesarean section: A comparative study
Damodar Puchakala1, Vidya Sagar Joshi2, Avanish Bhardwaj3
1 Department of Anaesthesiology, City Hospital, Karimnagar, Telangana, India
2 Commanding Officer, 4017 Field Hospital, Umroi, Shillong, Meghalaya, India
3 Department of Anaesthesiology, Command Hospital (Airforce), Bangalore, Karnataka, India
|Date of Submission||07-Apr-2021|
|Date of Acceptance||11-Aug-2021|
|Date of Web Publication||14-Mar-2022|
Dr. Avanish Bhardwaj
Department of Anaesthesiology, Command Hospital (Airforce), Old Airport Road, Post – Agram, Bangalore, Karnataka – 560 007
Source of Support: None, Conflict of Interest: None
Background: Pain after Caesarean section is described as moderate to severe by most patients. Ultrasound guided transversus abdominis plane (TAP) block is now increasingly being used for postoperative analgesia in lower abdominal surgeries. Hence this study was undertaken to compare 0.25% Bupivacaine with 0.375% Ropivacaine for postoperative analgesia using TAP block in caesarean section. Methods: Seventy patients were randomized into Group B (n = 35) and Group R (n = 35). TAP block was administered after completion of surgery under ultrasound guidance using 15 mL of 0.25% Bupivacaine in Group B and 15 mL of 0.375% Ropivacaine in Group R on each side of the abdomen. Time to requirement of first analgesic dosage was observed in both the groups. Total analgesic requirement in the first 24 h, visual analogue scale (VAS) scores at 2, 4, 6, 8, 12 and 24 h, patient satisfaction and complications were also noted. Results: Mean time for the first dose of rescue analgesia after completion of surgery was 298.2 ± 93.6 min in Group B and 447.6 ± 85.2 min in Group R (P = 0.0001). Total requirement of Diclofenac Sodium injection was 162.86 ± 46.88 mg in Group B whereas it was only 130.71 ± 44.49 mg in Group R (P = 0.003). VAS at 4,6 and 8 h after surgery were significantly lower in the Ropivacaine group. Conclusion: 0.375% Ropivacaine provided longer duration of analgesia and resulted in lesser analgesic requirement than 0.25% Bupivacaine when used in TAP block after caesarean section.
Keywords: Bupivacaine, ropivacaine, ultrasound guided transversus abdominis plane block
|How to cite this article:|
Puchakala D, Joshi VS, Bhardwaj A. Evaluation of 0.25% bupivacaine vs. 0.375% ropivacaine for postoperative analgesia using ultrasound guided transversus abdominis plane block for caesarean section: A comparative study. J Obstet Anaesth Crit Care 2022;12:17-21
|How to cite this URL:|
Puchakala D, Joshi VS, Bhardwaj A. Evaluation of 0.25% bupivacaine vs. 0.375% ropivacaine for postoperative analgesia using ultrasound guided transversus abdominis plane block for caesarean section: A comparative study. J Obstet Anaesth Crit Care [serial online] 2022 [cited 2022 Aug 12];12:17-21. Available from: https://www.joacc.com/text.asp?2022/12/1/17/339540
| Introduction|| |
Caesarean section is one of the most common surgical procedure performed these days. Approximately 15% of child births occur by caesarean section and this figure continues to rise with a fairly large number of present day mothers opting for an elective caesarean section over a normal vaginal delivery., Pain after caesarean section is described as moderate to severe by most of the patients. Failure to alleviate the pain impacts the bonding between mother and child and interferes with child care and breast feeding., Severe pain sometimes leads to immobility thereby increasing the risk of thromboembolism.
Various modalities including systemic opioids, non-steroidal anti-inflammatory drugs (NSAIDs) and epidural analgesia have been used for the purpose of reducing postoperative pain.,, Opioids are associated with undesirable effects like sedation and respiratory depression whereas NSAIDs as a single modality are most often insufficient to treat pain after Caesarean section. Epidural analgesia is a good alternative but the gravid uterus increases chances of dural and vascular punctures during insertion of needle or catheter besides it being a time consuming and technically demanding procedure in pregnant patients.,
Ultrasound guided (USG) transversus abdominis plane (TAP) block is a safe regional anaesthetic technique which is now increasingly being used for postoperative analgesia for caesarean section, hysterectomy and various other surgeries involving the lower abdomen.,,,, Ropivacaine and Bupivacaine are the most commonly used local anaesthetic (LA) agents used for administering TAP block., There have been many studies comparing 0.5% bupivacaine and 0.75% of ropivacaine when used for various peripheral nerve blocks and most of them have shown a similar efficacy when used in above-mentioned concentrations.,,, We undertook this prospective randomized study to compare 0.25% bupivacaine and 0.375% ropivacaine for postoperative analgesia using TAP block in caesarean section which is half the concentration of LA generally used for this purpose. Time to requirement of first analgesic dosage was the primary outcome of the study. Total analgesic requirement in the first 24 h, visual analogue scale (VAS) scores at 2, 4, 6, 8, 12, and 24 h, patient satisfaction and complications with both the local anaesthetics were the secondary outcomes.
| Materials and Methods|| |
After approval from Institutional ethical committee, this prospective randomized study was conducted in patients undergoing lower segment caesarean section (LSCS) surgery under spinal anaesthesia. All the patients undergoing elective LSCS under spinal anaesthesia were included in the study. Any patients with features of infection on the anterior abdominal wall, known history of allergy to the local anaesthetic drugs and coagulopathy were excluded from the study. Seventy patients were randomized two groups, the Bupivacaine group (Group B, n = 35) and Ropivacaine group (Group R, n = 35) using a computer generated algorithm and concealment done using opaque sealed envelope. Written informed consent was taken from all patients.
All the patients were administered spinal anaesthesia in either left lateral or sitting position using 2.4 mL of 0.5% Bupivacaine (Heavy). 26 Gauge Quincke's needle was used to administer the subarachnoid block in either L3-4 or L4-5 subarachnoid space. Inj Midazolam 1 mg intravenous and Inj Fentanyl 0.5 μg/kg body weight was administered after the delivery of the child if patient required any sedation, anxiolysis or analgesia. After the completion of surgery patients were administered USG guided TAP block on both the sides of the abdomen using a 21 Gauge needle and 6–13 MHz linear probe with the point of insertion between the costal margin and iliac crest in the anterior axillary line. 30 mL of 0.25% Bupivacaine was administered in Group B patients with 15 mL being injected on either side and similarly 30 mL of 0.375% Ropivacaine was injected in patients randomized to Group R with 15 mL on either side of the abdomen. Patient were assessed for pain in the postoperative period using a 10 cm long VAS scale with 0 being no pain and 10 being the worst imaginable pain at 2, 4, 6, 12, 18, and 24 h after surgery. Time to requirement of first dose of rescue analgesia was noted which was given when VAS >3. Injection Diclofenac Sodium 75 mg administered by intra muscular route was used for this purpose restricted to a maximum of 3 doses in 24 h with a gap of 8 h in between two doses. Adequate hydration was maintained for all the patients. Total requirement of rescue analgesia in 24 h was noted in both the groups. Any postoperative complications and patient satisfaction in both the groups was recorded.
Statistical analysis: Taking results of other similar studies performed elsewhere we presumed that the time to first requirement of rescue analgesia would be at least 60 min less in the Bupivacaine group when compared to Ropivacaine group. With SD of ± 2.5 a sample size of 35 cases was considered adequate for a study with 80% Power and 95% Confidence interval. Quantitative data is presented as mean ± SD. For normally distributed data mean has been compared using unpaired t-test. For skewed data or scores Mann-Whitney test was applied. Categorical variables have been presented as number and percentages. Chi-square test or Fisher's exact test has been applied for categorical data. Ordinal data has also been presented as number and percentage. Between two groups it has been compared using Mann Whitney test. All calculations are two sided and were performed using SPSS version 20 (Statistical Packages for the Social Sciences, Chicago, IL). A P value of <0.05 has been considered statistically significant.
| Results|| |
Out of 80 patients assessed for eligibility, 70 patients were enrolled and randomized into Group B and Group R with 35 patients in each group. All these patients completed the study and the data obtained from them was used for statistical analysis. [Figure 1] Both the groups were similar in terms of patient characteristics, duration of surgery and the requirement of intraoperative sedation, anxiolysis or analgesia [Table 1].
Patients were followed up in the postoperative period. Mean time for the first dose of rescue analgesia after completion of surgery was 298.2 ± 93.6 min in Group B and 447.6 ± 85.2 min in Group R (P = 0.0001). Total requirement of Diclofenac Sodium injection was 162.86 ± 46.88 mg in Group B whereas it was only 130.71 ± 44.49 mg in Group R (P = 0.003) [Table 2].
VAS scores for pain in the postoperative period were compared in both the groups. No difference was noted in pain scores at 2, 12 and 24 h in between both the groups but pain scores at 4, 6 and 8 h after surgery were significantly lower in the Ropivacaine group [Table 3]. Both the groups were identical in terms of patient satisfaction (P = 0.26) [Table 4]. No complications related to local anaesthetics were noted in either of the groups.
| Discussion|| |
Severity of pain after caesarean section has been described as moderate to severe by most of the patients and this may interfere not only with care of the new born child and breastfeeding but also impair the bonding between the mother and the child., Besides the risk of thromboembolism also increases as the ambulation of the mother may be delayed because of pain. Hence it is of utmost importance that the pain is alleviated considerably to avoid the above mentioned situations. USG guided TAP block has emerged as one of the frontrunners among the modalities available for pain relief in such subset of patients owing to its efficacy, safety and ease of administration.,,
Bupivacaine and Ropivacaine are the most commonly used local anaesthetic for TAP block these days and there have been many studies comparing the efficacy of 0.5% Bupivacaine with 0.75% of Ropivacaine when used for various types of peripheral nerve blocks.,,,, However the data comparing these two agents for postoperative analgesia among patients undergoing caesarean section is lacking. We know that pregnant patients are more prone to systemic toxicity of local anaesthetics in the immediate postoperative period due to reduced albumin concentration and lower plasma binding. Hence we decided to use 0.25% of Bupivacaine and 0.375% Ropivacaine in our study which is half the concentration of LA used for such purposes.
After the surgery first dose of analgesic was administered at 298.2 ± 93.6 min in the in the Bupivacaine group and 447.6 ± 85.2 min in the Ropivacaine group (P = 0.0001). As mentioned earlier we could not find any studies in the literature where both these agents have been compared for this subset of patients. However we could find three studies comparing bupivacaine and ropivacaine for postoperative analgesia in various other surgeries.,, In the study by Fuladi N et al. 75 adult patients undergoing elective unilateral lower abdominal surgery were randomized to undergo TAP block with ropivacaine (n = 25), bupivacaine (n = 25) or normal saline (n = 25). At end of surgery performed under spinal anaesthesia unilateral TAP block on side of surgery was performed using 20 mL of 0.5% ropivacaine or 0.25% bupivacaine or saline. Each patient was assessed postoperatively every 5 min for half an hour, then every 15 min till 2 h and at 4, 6, 12, 24, 48 h postoperatively in ward. The authors found out that the mean duration of analgesia was 420.6 ± 14.01 min in Bupivacaine group and 2187 ± 1011.09 min in Ropivacaine group and the difference was found to be statistically significant.
In the study by Sharma N et al. 60 adult patients undergoing elective abdominal surgery under general anaesthesia were randomly divided into two groups and after induction of anaesthesia received unilateral or bilateral TAP Block (depending upon nature of incision of surgery) using either 15 mL of 0.5% Ropivacaine or 0.25% Bupivacaine on each side. Post-operatively patients were assessed for pain with VAS score at 0 min, 30 min, 4, 8, 12, 18 and 24 h. Mean duration of analgesia in Ropivacaine group and Bupivacaine group was 12.61 ± 5.13 hrs and 9.92 ± 4.81 h, respectively, and the difference was found to be statistically significant.
Our study has similar findings wherein the duration of analgesia in the Ropivacaine group is significantly more than the Bupivacaine group. However the duration of analgesia in our study is comparatively less than what has been observed in other two studies. This could be attributed to the fact that the strength of Ropivacaine used in both the studies is 0.5% whereas in our study we used 0.375%. In the study by Fuladi N et al., 20 mL of local anaesthetic was used and the surgeries were only on one side of the abdomen. In the study by Sharma N et al. also a lot of patients underwent surgery only on one side of the abdomen and this could have contributed to the difference in duration of analgesia achieved in their studies vis-à-vis our study., Nevertheless it is Ropivacaine which has more prolonged analgesia as observed by all three studies. Ropivacaine has some intrinsic vasoconstrictor properties and this to could have led to the difference in the duration of analgesia achieved by both the local anaesthetics.,
Total requirement of Diclofenac Sodium injection over a period of 24 h was 162.86 ± 46.88 mg in Group B whereas it was only 130.71 ± 44.49 mg in Group R (P = 0.003). This difference is on anticipated lines as most of the patients required 3 doses of Diclofenac Sodium in the Bupivacaine group whereas a majority of patients in the Ropivacaine group required only 2 doses due to longer duration of analgesia achieved. Our results are different from another study where even though the total postoperative analgesic requirement in Bupivacaine group was higher than the Ropivacaine group but the difference was not statistically significant. In the study by Sinha S et al., 60 adults undergoing elective laparoscopic cholecystectomy were randomised to receive ultrasoundguided TAP block at the end of the surgical procedure with either 0.25% bupivacaine or 0.375% ropivacaine. All patients were assessed for postoperative pain and rescue analgesic consumption at 10 min, 30 min, 1 h, 4 h, 8 h, 12 h and 24 h time points. They also did not find any difference in the 24 h cumulative analgesic requirement in between both the groups. The results of both these studies are different from us in terms of 24 hour cumulative analgesic requirement but it will be prudent to note here that the subset of patients and type surgery in our study is entirely different from that in the above mentioned studies.
VAS scores for pain in the postoperative period were comparable in both the groups at 2, 12 and 24 h but pain scores at 4,6 and 8 h after surgery were significantly lower in the Ropivacaine group in our study. It is attributable to the fact that the analgesia lasted comparatively longer in the Ropivacaine group and hence better pain scores in intermediate duration. However it is similar at 2 h as the effect of local anaesthetic would be present equally in both the groups whereas at 12 and 24 h the effect would have dissipated in both the groups and hence the VAS scores would again be similar. Fuladi N et al. reported lower VAS scores with Ropivacaine at 2, 4, 6 and 12 h whereas Sharma N et al. reported significantly lower VAS scores at 8 and 12 h after cessation of surgery. However in the study by Sinha S et al. VAS scores with Ropivacaine were lower only at 10, 30 and 60 min after surgery and the authors did not find any significant difference in VAS scores at 4, 8, 12 and 24 h.
Patient satisfaction is an important aspect and our study is unique in this regard as not many studies had looked into patient satisfaction with the use of various drugs. Both Bupivacaine and Ropivacaine were found to have similar levels of satisfaction and none of the patients were unsatisfied with the use of either Bupivacaine or Ropivacaine in our study. Also none of the patients in either groups had any complications associated with the technique as well as Local anaesthetics.
We did not compare 0.25% Bupivacaine and 0.375% Ropivacaine with either Placebo or other conventional modalities of pain relief like NSAIDs or opioids and this is one of the limitations of the study. Besides the assessment of pain scores was not continuous but at specific time periods which could have altered the total analgesic requirement. We also could have used more volume of the drug not exceeding the toxic dose which could have further prolonged the duration of analgesia achieved with both the agents.
Nevertheless within limitations of our study we conclude that 0.375% Ropivacaine provided longer duration of analgesia than 0.25% Bupivacaine when used in ultrasound guided TAP block for postoperative analgesia after caesarean section. Also the total analgesic requirement was lower with the use of Ropivacaine. Hence Ropivacaine can be used as a safe alternative for Bupivacaine, routinely for TAP block after caesarean section. We also recommend that further studies may be undertaken in this subset of patients using the increased concentrations or volume of both the local anaesthetics, not exceeding the safe limits of their dosage to see if more prolonged analgesia can be achieved which may further reduce the analgesic requirement, without causing any adverse effects.
Department of Obstetrics and Gynecology, Command Hospital (Airforce), Bangalore.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Gibbons L, Belizán JM, Lauer JA, Betrán AP, Merialdi M, Althabe F. The global numbers and costs of additionally needed and unnecessary caesarean sections performed per year: Overuse as a barrier to universal coverage. World Health Report 2010;30:1-31.
Gibbons L, Belizan JM, Lauer JA, Betran AP, Merialdi M, Althabe F. Inequities in the use of cesarean section deliveries in the world. Am J Obstet Gynecol 2012;206:331.e1-19.
Karlström A, Engström-Olofsson R, Norbergh KG, Sjöling M, Hildingsson I. Postoperative pain after cesarean birth affects breastfeeding and infant care. J Obstet Gynecol Neonat Nurs 2007;36:430-40.
Eisenach JC, Pan PH, Smiley R, Lavand'homme P, Landau R, Houle TT. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain 2008;140:87-94.
Daniel DG, Campbell H, Turnbull AC. Puerperal thromboembolism and suppression of lactation. Lancet 1967;290:287-9.
Dahl JB, Kehlet H. The value of pre-emptive analgesia in the treatment of postoperative pain. Br J Anaesth 1993;70:434-9.
Gadsden J, Hart S, Santos AC. Post-cesarean delivery analgesia. Anesth Analg 2005;101:S62-9.
McDonnell NJ, Keating ML, Muchatuta NA, Pavy TJ, Paech MJ. Analgesia after caesarean delivery. Anaesth Intensive Care 2009;37:539-51.
Olofsson CI, Legeby MH, Nygårds EB, Östman KM. Diclofenac in the treatment of pain after caesarean delivery: An opioid-saving strategy. Eur J Obstet Gynecol Reprod Biol 2000;88:143-6.
Bonouvrie K, van den Bosch A, Roumen FJ, van Kuijk SM, Nijhuis JG, Evers SM, et al
. Epidural analgesia during labour, routinely or on request: A cost effectiveness analysis. Eur J Obstet Gynecol Reprod Biol 2016;207:23-31.
Schnittger T. Regional anaesthesia in developing countries. Anaesthesia 2007;62:44-7.
Johns N, O'neill S, Ventham NT, Barron F, Brady RR, Daniel T. Clinical effectiveness of transversus abdominis plane (TAP) block in abdominal surgery: A systematic review and meta-analysis. Colorectal Dis 2012;14:e635-42.
Niraj G, Kelkar A, Jeyapalan I, Graff-Baker P, Williams O, Darbar A, et al
. Comparison of analgesic efficacy of subcostal transversus abdominis plane blocks with epidural analgesia following upper abdominal surgery. Anaesthesia 2011;66:465-71.
Jankovic Z. Transversus abdominis plane block: The holy grail of anaesthesia for (lower) abdominal surgery. Period Biol 2009;111:203-8.
Mukhtar K. Transversus abdominis plane (TAP) block. JNY School Reg Anesth 2009;12:28-33.
Bonnet F, Berger J, Aveline C. Transversus abdominis plane block: What is its role in postoperative analgesia? Br J Anaesth 2009;103:601–5.
McClellan KJ, Faulds D. Ropivacaine. Drugs 2000;60:1065-93.
Rahiri J, Tuhoe J, Svirskis D, Lightfoot NJ, Lirk PB, Hill AG. Systematic review of the systemic concentrations of local anaesthetic after transversus abdominis plane block and rectus sheath block. Br J Anaesth 2017;118:517-26.
Brockway MS, Bannister J, McClure JH, McKeown D, Wildsmith JA. Comparison of extradural ropivacaine and bupivacaine. Br J Anaesth 1991;66:31-7.
Klein SM, Greengrass RA, Steele SM, D'Ercole FJ, Speer KP, Gleason DH, et al
. A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block. Anesth Analg 1998;87:1316-9.
Bertini L, Tagariello V, Mancini S, Ciaschi A, Posteraro CM, Di Benedetto P, et al
. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: A clinical comparison with 0.5% bupivacaine. Reg Anesth Pain Med 1999;24:514-8.
Gioia L, Prandi E, Codenotti M, Casati A, Fanelli G, Torri TM, et al
. Peribulbar anesthesia with either 0.75% ropivacaine or a 2% lidocaine and 0.5% bupivacaine mixture for vitreoretinal surgery: A double-blinded study. Anesth Analg 1999;89:739-42.
Belavy D, Cowlishaw PJ, Howes M, Phillips F. Ultrasound-guided transversus abdominis plane block for analgesia after Caesarean delivery. Br J Anaesth 2009;103:726–30.
Baaj JM, Alsatli RA, Majaj HA, Babay ZA, Thallaj AK. Efficacy of ultrasound-guided transversus abdominis plane (TAP) block for postcesarean section delivery analgesia – A double-blind, placebo-controlled, randomized study. Middle East J Anaesthesiol 2010;20:821–6.
Abdallah FW, Halpern SH, Margarido CB. Transversus abdominis plane block for postoperative analgesia after Caesarean delivery performed under spinal anesthesia? A systematic review and meta-analysis. Br J Anaesth 2012;109:679–87.
Nejdlova M, Johnson T. Anaesthesia for non-obstetric procedures during pregnancy. Contin Educ Anaesth Crit Care Pain 2012;12:203–6.
Fuladi N, Deshmukh S, Bhure A. Comparative study of bupivacaine 0.25% versus ropivacaine 0.5% in transversus abdominis plane block for postoperative analgesia in lower abdominal surgeries: A randomised controlled trial. J Evol Med Dent Sci 2014;3:4569-76.
Sharma N, Mehta N, Sharma S. An evaluation of 0.25% bupivacaine vs. 0.5% ropivacaine for postoperative analgesia using ultrasound guided transversus abdominis plane block for abdominal surgeries: A comparative study. Indian J Clin Anaesth 2016;3:635-9.
Sinha S, Palta S, Saroa R, Prasad A. Comparison of ultrasound-guided transversus abdominis plane block with bupivacaine and ropivacaine as adjuncts for postoperative analgesia in laparoscopic cholecystectomies. Indian J Anaesth 2016;60:264–9.
] [Full text]
McClure JH. Ropivacaine. Br J Anaesth 1996;76:300-7.
[Table 1], [Table 2], [Table 3], [Table 4]